Tuesday, 16 September 2025
  
Login

Australia's most trusted
source of pharma news

Tuesday, 16 September 2025
IQVIA
IQVIA
Drugs turning away from the PBS

New analysis of the PBAC's 'use it or lose it' reviews shows which recommended drugs will not reach PBS funding and for most, it seems, failed negotiations over pricing is to blame.

Forging path for next-gen therapy
New not-for-profit is bringing disparate parts of the health system together to ease access to a new type of cancer treatment
TODAY
Four say 'no more' to UK
Four Big Pharma's have either cancelled or paused investment in the UK with warnings Australia needs to lift its game
TODAY
Medscape
Medscape
Aussie GM departs for top job
IIn a major promotion another Aussie country leader is packing up for a new gig, with a successor already named
15 September
Is pharma company loyalty dead?
Australian pharma industry survey reveals more than 8 in 10 are open to new job opportunities or are actively seeking a new role
15 September
Bride that made pharma history
Thirty years after this photo was taken a high-flying company boss gives a rare, personal insight into how she got so lucky
12 September
Who's to blame for pharma's slump?
After resisting headwinds for a year, the market cap of 80 per cent of the Top 20 pharmas has taken a hit with analysts laying blame
12 September
Next
Next
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (16)

Clinical & Medical, R&D (10)

Regulatory, Pharmacovigilance & QA (6)

Devices (1)

Other (7)

Kids play heroes in education push
Global awareness campaign kicks off in Australia with primary school children, the first graduates of a unique pharma program
15 September
Radio drug hits another hurdle
While the committee found there's "likely a clinical place" for the therapy, it's back to the drawing board for this company
15 September
Rival gains ground in hot market
Bayer's non-hormonal menopause treatment has been TGA approved closing in on rival, Astellas which is heading to PBAC
15 September Approvals Action
Jobs go in company shake-up
ICYMI: Another company undergoes a major overhaul, plus the other most popular stories this week
12 September Your Week in 5 Minutes
Blood cancer funding under review
Stakeholders discuss how to improve the treatment regimen for multiple myeloma, with clinicians asking for more freedom
12 September
Cancer summit tackles equity
Medical experts, pharmas, patient advocates and policymakers meet to thrash out a better future for those with cancer
12 September
Pharma exits 27 markets
600-plus jobs to go as the company transitions to a partnership model for commercialisation... but the Australian team is spared
11 September
Company rolls out 9000 job cuts
Transformation aims to simplify operations, speed decision-making and redirect resources to growing its flagship business
11 September
Aussies take home APAC Awards
Companies at the forefront of next-gen cancer treatment have won peer-voted excellence awards for their work
11 September
Game changer wins GSK grant
Cutting-edge approach to infectious disease combining AI and genetic sequencing takes out prestigious $150,000 prize
11 September
Takeda to awaken US$9B market
Company heads to global regulators with a first-in-class treatment for narcolepsy after outstanding Phase 3 trial results
11 September
Judge opens door to $500M market
Court declines an interlocutory injunction, paving the way for Sandoz to launch its biosim in a $500M blockbuster market
10 September
Meet industry's highest paid KOLs
See the Top 10 clinicians receiving the highest payments from pharma as well as which companies forked out how much
10 September
Pfizer pushes back on Trump rant
Sets the record straight on claims by the US President that it has failed to release the scientific findings of its drugs
10 September
PiF advertise
PiF advertise
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.